Bevacizumab intravítreo en el tratamiento de la neovascularización subretiniana secundaria a rotura coroidea

X. Valldeperas; R. Bonilla; M. R. Romano; J. De La Cámara

doi:10.1016/j.oftal.2011.05.019

Bevacizumab intravítreo en el tratamiento de la neovascularización subretiniana secundaria a rotura coroidea

Translated title of the contribution: Use of intravitreal bevacizumab for the treatment of choroidal neovascularization secondary to choroidal rupture

X. Valldeperas, R. Bonilla, M. R. Romano, J. De La Cámara

Istituto Clinico Humanitas

Research output: Contribution to journal › Article

Abstract

Case report: A 28 year-old male attended our Emergency Department with a traumatic choroidal rupture and macular haemorrhage. After pneumatic displacement of the haemorrhage with C ₃F ₈ and tissue plasminogen activator, the haemorrhage was reabsorbed and visual acuity (VA) improved. Three months later the patient presented with decreased VA and a juxtafoveal choroidal neovascularisation (CNV) that was treated with intravitreal bevacizumab. One year after a single bevacizumab injection the CNV remained inactive, with a final VA of 0.5. Discussion: Intravitreal bevacizumab injection is a new and effective treatment for traumatic CNV. In our patient, in contrast to other aetiologies, the CNV needed no more than one Avastin ^® injection to be inactivated, after one year of follow-up.

Translated title of the contribution	Use of intravitreal bevacizumab for the treatment of choroidal neovascularization secondary to choroidal rupture
Original language	Spanish
Pages (from-to)	380-383
Number of pages	4
Journal	Archivos de la Sociedad Espanola de Oftalmologia
Volume	86
Issue number	11
DOIs	https://doi.org/10.1016/j.oftal.2011.05.019
Publication status	Published - Nov 2011

Keywords

Bevacizumab
Choroidal neovascularisation
Choroidal rupture
Ocular traumatism
Pneumatic displacement
Recombinant tissue plasminogen activator (rTPA)
Submacular haemorrhage

ASJC Scopus subject areas

Ophthalmology

Access to Document

10.1016/j.oftal.2011.05.019

Fingerprint Dive into the research topics of 'Use of intravitreal bevacizumab for the treatment of choroidal neovascularization secondary to choroidal rupture'. Together they form a unique fingerprint.

Cite this

Valldeperas, X., Bonilla, R., Romano, M. R., & De La Cámara, J. (2011). Bevacizumab intravítreo en el tratamiento de la neovascularización subretiniana secundaria a rotura coroidea. Archivos de la Sociedad Espanola de Oftalmologia, 86(11), 380-383. https://doi.org/10.1016/j.oftal.2011.05.019

@article{827e7b9b59c8430f8e1e2a14e647bba2,

title = "Bevacizumab intrav{\'i}treo en el tratamiento de la neovascularizaci{\'o}n subretiniana secundaria a rotura coroidea",

abstract = "Case report: A 28 year-old male attended our Emergency Department with a traumatic choroidal rupture and macular haemorrhage. After pneumatic displacement of the haemorrhage with C 3F 8 and tissue plasminogen activator, the haemorrhage was reabsorbed and visual acuity (VA) improved. Three months later the patient presented with decreased VA and a juxtafoveal choroidal neovascularisation (CNV) that was treated with intravitreal bevacizumab. One year after a single bevacizumab injection the CNV remained inactive, with a final VA of 0.5. Discussion: Intravitreal bevacizumab injection is a new and effective treatment for traumatic CNV. In our patient, in contrast to other aetiologies, the CNV needed no more than one Avastin {\textregistered} injection to be inactivated, after one year of follow-up.",

keywords = "Bevacizumab, Choroidal neovascularisation, Choroidal rupture, Ocular traumatism, Pneumatic displacement, Recombinant tissue plasminogen activator (rTPA), Submacular haemorrhage",

author = "X. Valldeperas and R. Bonilla and Romano, {M. R.} and {De La C{\'a}mara}, J.",

year = "2011",

month = nov,

doi = "10.1016/j.oftal.2011.05.019",

language = "Spagnolo",

volume = "86",

pages = "380--383",

journal = "Archivos de la Sociedad Espanola de Oftalmologia",

issn = "0365-6691",

publisher = "Elsevier Limited",

number = "11",

}

TY - JOUR

T1 - Bevacizumab intravítreo en el tratamiento de la neovascularización subretiniana secundaria a rotura coroidea

AU - Valldeperas, X.

AU - Bonilla, R.

AU - Romano, M. R.

AU - De La Cámara, J.

PY - 2011/11

Y1 - 2011/11

N2 - Case report: A 28 year-old male attended our Emergency Department with a traumatic choroidal rupture and macular haemorrhage. After pneumatic displacement of the haemorrhage with C 3F 8 and tissue plasminogen activator, the haemorrhage was reabsorbed and visual acuity (VA) improved. Three months later the patient presented with decreased VA and a juxtafoveal choroidal neovascularisation (CNV) that was treated with intravitreal bevacizumab. One year after a single bevacizumab injection the CNV remained inactive, with a final VA of 0.5. Discussion: Intravitreal bevacizumab injection is a new and effective treatment for traumatic CNV. In our patient, in contrast to other aetiologies, the CNV needed no more than one Avastin ® injection to be inactivated, after one year of follow-up.

AB - Case report: A 28 year-old male attended our Emergency Department with a traumatic choroidal rupture and macular haemorrhage. After pneumatic displacement of the haemorrhage with C 3F 8 and tissue plasminogen activator, the haemorrhage was reabsorbed and visual acuity (VA) improved. Three months later the patient presented with decreased VA and a juxtafoveal choroidal neovascularisation (CNV) that was treated with intravitreal bevacizumab. One year after a single bevacizumab injection the CNV remained inactive, with a final VA of 0.5. Discussion: Intravitreal bevacizumab injection is a new and effective treatment for traumatic CNV. In our patient, in contrast to other aetiologies, the CNV needed no more than one Avastin ® injection to be inactivated, after one year of follow-up.

KW - Bevacizumab

KW - Choroidal neovascularisation

KW - Choroidal rupture

KW - Ocular traumatism

KW - Pneumatic displacement

KW - Recombinant tissue plasminogen activator (rTPA)

KW - Submacular haemorrhage

UR - http://www.scopus.com/inward/record.url?scp=80255136150&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80255136150&partnerID=8YFLogxK

U2 - 10.1016/j.oftal.2011.05.019

DO - 10.1016/j.oftal.2011.05.019

M3 - Articolo

C2 - 22040647

AN - SCOPUS:80255136150

VL - 86

SP - 380

EP - 383

JO - Archivos de la Sociedad Espanola de Oftalmologia

JF - Archivos de la Sociedad Espanola de Oftalmologia

SN - 0365-6691

IS - 11

ER -